Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216479634> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- W3216479634 abstract "Introduction: The evidence-based optimal medical therapy has been encouraged in the treatment of patients with coronary artery disease. However, as follow-up periods are limited (-5 years) in the most of randomized trials, prognostic efficacy of drugs in longer time period has not been fully evaluated. Therefore, this registry-based study aimed to simultaneously address the long-term prognostic impact of 6 major classes of cardiovascular (CV) drugs, beta-blockers (BBs), calcium channel blockers (CCBs), angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), Statins and Non-aspirin antiplatelets following percutaneous coronary intervention (PCI). Methods and Results: This is an analyses of single center prospective registry with lengthy history launched in 1984. Consecutive 6,299 patients underwent first PCI between 1984 and 2018 were included and CV mortality was set as the endpoint. Median and the range of follow-up period is 8.8, 0-28.9 years, respectively. Cox proportional hazard analyses adjusted by age, gender, BMI, diabetes and cardiac and renal function simultaneously evaluated the prognostic impacts of 6 major CV drugs in the entire population and patients with acute coronary syndrome (ACS). Among 6 drugs, ARBs (Hazard Ratio (HR): 0.72, 95% confidence interval (95% CI): 0.55-0.93, p=0.01), Non-aspirin antiplatelets (0.67, 0.53-0.86, p=0.002) and Statins (0.56, 0.44-0.7, p<0.001) were significantly associated with reduced risk of CV mortality in the entire PCI population ( Figure A ). In ACS patients (n=1,790), only Statins at PCI predicted the reduced risk of CV mortality (HR: 0.44, 95%CI 0.28-0.68 p<0.001) ( Figure B ). Conclusions: This long-term PCI registry-based analyses demonstrated the significant prognostic efficacy of ARBs, antiplatelets other than aspirin and statins. In ACS patients, only Statins, not other 5 classes of major CV drugs, were associated with reduced risk of CV mortality." @default.
- W3216479634 created "2021-12-06" @default.
- W3216479634 creator A5000117746 @default.
- W3216479634 creator A5001915586 @default.
- W3216479634 creator A5005952657 @default.
- W3216479634 creator A5015932449 @default.
- W3216479634 creator A5028858557 @default.
- W3216479634 creator A5032939425 @default.
- W3216479634 creator A5033092933 @default.
- W3216479634 creator A5033748652 @default.
- W3216479634 creator A5039065380 @default.
- W3216479634 creator A5042369450 @default.
- W3216479634 creator A5057752010 @default.
- W3216479634 creator A5058793966 @default.
- W3216479634 creator A5074027680 @default.
- W3216479634 creator A5076375061 @default.
- W3216479634 creator A5077670585 @default.
- W3216479634 creator A5082760754 @default.
- W3216479634 creator A5089383750 @default.
- W3216479634 date "2021-11-16" @default.
- W3216479634 modified "2023-10-18" @default.
- W3216479634 title "Abstract 10942: Comparison of Long-Term Prognostic Impact of 6 Major Cardiovascular Drugs in Patients Following Coronary Intervention; Analysis from the Registry Database with the 35-Year History" @default.
- W3216479634 doi "https://doi.org/10.1161/circ.144.suppl_1.10942" @default.
- W3216479634 hasPublicationYear "2021" @default.
- W3216479634 type Work @default.
- W3216479634 sameAs 3216479634 @default.
- W3216479634 citedByCount "0" @default.
- W3216479634 crossrefType "journal-article" @default.
- W3216479634 hasAuthorship W3216479634A5000117746 @default.
- W3216479634 hasAuthorship W3216479634A5001915586 @default.
- W3216479634 hasAuthorship W3216479634A5005952657 @default.
- W3216479634 hasAuthorship W3216479634A5015932449 @default.
- W3216479634 hasAuthorship W3216479634A5028858557 @default.
- W3216479634 hasAuthorship W3216479634A5032939425 @default.
- W3216479634 hasAuthorship W3216479634A5033092933 @default.
- W3216479634 hasAuthorship W3216479634A5033748652 @default.
- W3216479634 hasAuthorship W3216479634A5039065380 @default.
- W3216479634 hasAuthorship W3216479634A5042369450 @default.
- W3216479634 hasAuthorship W3216479634A5057752010 @default.
- W3216479634 hasAuthorship W3216479634A5058793966 @default.
- W3216479634 hasAuthorship W3216479634A5074027680 @default.
- W3216479634 hasAuthorship W3216479634A5076375061 @default.
- W3216479634 hasAuthorship W3216479634A5077670585 @default.
- W3216479634 hasAuthorship W3216479634A5082760754 @default.
- W3216479634 hasAuthorship W3216479634A5089383750 @default.
- W3216479634 hasConcept C126322002 @default.
- W3216479634 hasConcept C164705383 @default.
- W3216479634 hasConcept C207103383 @default.
- W3216479634 hasConcept C2777628954 @default.
- W3216479634 hasConcept C2777698277 @default.
- W3216479634 hasConcept C2777849778 @default.
- W3216479634 hasConcept C2778213512 @default.
- W3216479634 hasConcept C2780400711 @default.
- W3216479634 hasConcept C2908647359 @default.
- W3216479634 hasConcept C44249647 @default.
- W3216479634 hasConcept C45393284 @default.
- W3216479634 hasConcept C500558357 @default.
- W3216479634 hasConcept C50382708 @default.
- W3216479634 hasConcept C71924100 @default.
- W3216479634 hasConcept C99454951 @default.
- W3216479634 hasConceptScore W3216479634C126322002 @default.
- W3216479634 hasConceptScore W3216479634C164705383 @default.
- W3216479634 hasConceptScore W3216479634C207103383 @default.
- W3216479634 hasConceptScore W3216479634C2777628954 @default.
- W3216479634 hasConceptScore W3216479634C2777698277 @default.
- W3216479634 hasConceptScore W3216479634C2777849778 @default.
- W3216479634 hasConceptScore W3216479634C2778213512 @default.
- W3216479634 hasConceptScore W3216479634C2780400711 @default.
- W3216479634 hasConceptScore W3216479634C2908647359 @default.
- W3216479634 hasConceptScore W3216479634C44249647 @default.
- W3216479634 hasConceptScore W3216479634C45393284 @default.
- W3216479634 hasConceptScore W3216479634C500558357 @default.
- W3216479634 hasConceptScore W3216479634C50382708 @default.
- W3216479634 hasConceptScore W3216479634C71924100 @default.
- W3216479634 hasConceptScore W3216479634C99454951 @default.
- W3216479634 hasIssue "Suppl_1" @default.
- W3216479634 hasLocation W32164796341 @default.
- W3216479634 hasOpenAccess W3216479634 @default.
- W3216479634 hasPrimaryLocation W32164796341 @default.
- W3216479634 hasRelatedWork W2019045182 @default.
- W3216479634 hasRelatedWork W2037681348 @default.
- W3216479634 hasRelatedWork W2095220707 @default.
- W3216479634 hasRelatedWork W2170949977 @default.
- W3216479634 hasRelatedWork W2375232986 @default.
- W3216479634 hasRelatedWork W2788692878 @default.
- W3216479634 hasRelatedWork W3032140106 @default.
- W3216479634 hasRelatedWork W3134798512 @default.
- W3216479634 hasRelatedWork W3198027009 @default.
- W3216479634 hasRelatedWork W45326695 @default.
- W3216479634 hasVolume "144" @default.
- W3216479634 isParatext "false" @default.
- W3216479634 isRetracted "false" @default.
- W3216479634 magId "3216479634" @default.
- W3216479634 workType "article" @default.